This topic contains a solution. Click here to go to the answer

Author Question: Given that the critical value (.05 level, two-tailed) is __________, the researcher's decision ... (Read 7 times)

tfester

  • Hero Member
  • *****
  • Posts: 534
Given that the critical value (.05 level, two-tailed) is __________, the researcher's decision should be __________.
 
  Fill in the blanks with correct word

Question 2

If an organizational psychologist conducts extensive interviews with 40 workers at a large factory to examine the morale among workers in general at that factory, the population is
 
  A) the 40 workers interviewed.
  B) all the workers in the factory except the 40 interviewed.
  C) all the workers in the factory.
  D) all the workers necessary to create a normal distribution.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

mcomstock09

  • Sr. Member
  • ****
  • Posts: 377
Answer to Question 1

2.306 ; do not reject the null hypothesis

Answer to Question 2

C




tfester

  • Member
  • Posts: 534
Reply 2 on: Jun 20, 2018
:D TYSM


Dinolord

  • Member
  • Posts: 313
Reply 3 on: Yesterday
Excellent

 

Did you know?

Sildenafil (Viagra®) has two actions that may be of consequence in patients with heart disease. It can lower the blood pressure, and it can interact with nitrates. It should never be used in patients who are taking nitrates.

Did you know?

Critical care patients are twice as likely to receive the wrong medication. Of these errors, 20% are life-threatening, and 42% require additional life-sustaining treatments.

Did you know?

The lipid bilayer is made of phospholipids. They are arranged in a double layer because one of their ends is attracted to water while the other is repelled by water.

Did you know?

In the United States, there is a birth every 8 seconds, according to the U.S. Census Bureau's Population Clock.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library